Faculty of Biology, Medicine and Health

The University of Manchester

  Understanding the factors that influence psychosocial functioning in older people with bipolar disorder

  , ,  Applications accepted all year round  Self-Funded PhD Students Only

About the Project

Bipolar disorder is classified as a lifelong, recurrent condition, associated with functional decline and a reduction in quality of life (Michalak et al., 2005Bonnín et al., 2012). Older adults are estimated to represent approximately 25% of people diagnosed with bipolar disorder (Ljubic et al., 2021). This number is set to increase as our population ages and the awareness of the condition improves (Sajatovic et al., 2015). 

Bipolar disorder in later life is more complex, with high rates of physical comorbidities (Warner et al., 2023) and poorer cognitive function compared to age-matched controls (Samame et al, 2013). This may impact on a person’s functioning in later life and lead to difficulties with finances, domestic roles, mobility, and social and recreational activities (Chen et al, 2017).

This PhD project aims to understand the factors that influence psychosocial functioning in older people with bipolar. The first stage of the PhD will involve undertaking a meta-synthesis of existing studies that have focused on individuals diagnosed with a severe and enduring mental health difficulties and their experiences of ageing. The second stage aims to identify factors that predict functioning in older people with bipolar and identify participants who score high and low on the functioning scales (whilst controlling for factors that affect functioning e.g., current mood state). This will involve recruiting a sample of 80 older people with bipolar from NHS services, voluntary services and mental health charities and asking them to complete a number of different assessment measures.

The final stage of the PhD aims to understand some of the factors that may influence functioning for older people with bipolar. Twenty participants who scored either high or low on the measures at stage two will be asked to take part in a semi-structured interview. The interviews will be analysed using qualitative methods. 

Training/techniques to be provided

All students enrolled on a PhD in the department will have access to the Master’s of Research Psychology courses in statistics, qualitative methods and systematic reviews. The library also offers support to students that are undertaking a systematic review as part of their studies. The University of Manchester and National Institute of Health Research (NIHR) offer courses in the area of patient and public involvement (PPI), Equality, Diversity and inclusion (EDI). There will also be the opportunity to pay for external courses to support the students training and development and the attendance at conferences such as the British Association of Behavioural and Cognitive therapies (BABCP). More intensive supervision and bespoke training will be provided by the core supervisory team who have in-depth knowledge in the subject area and the necessary methodological expertise needed to undertake the proposed PhD. 

Entry Requirements

Candidates are expected to hold a minimum upper second-class honours degree in Psychology or a related discipline.

A master’s degree is desirable. 

How to Apply

For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (https://www.bmh.manchester.ac.uk/study/research/apply/). Informal enquiries may be made directly to the primary supervisor. On the online application form select the PhD Psychology and Mental Health.

For international students, we also offer a unique 4 year PhD programme that gives you the opportunity to undertake an accredited Teaching Certificate whilst carrying out an independent research project across a range of biological, medical and health sciences. For more information please visit https://www.bmh.manchester.ac.uk/study/research/international/

Equality, Diversity & Inclusion

Equality, diversity and inclusion is fundamental to the success of The University of Manchester, and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the website

https://www.bmh.manchester.ac.uk/study/research/apply/equality-diversity-inclusion/

Psychology (31)

Funding Notes

Applications are invited from self-funded students. This project has a Band 1 fee.
Details of our different fee bands can be found on our website View Website

References

Warner, A., Lobban, F., Holland, C., Tyler, E., Settle, G., Rhodes, V., & Palmier-Claus, J. (2023) What does it mean to age well with bipolar disorder? A qualitative study using photo elicitation. Psychology and Psychotherapy: Theory, Research and Practice. https://doi.org/10.1111/papt.12501
Warner, A., Holland, C., Lobban, F., Tyler, E., Harvey, D., Newens, C., & Palmier-Claus, J. (2023). Physical health comorbidities in older adults with bipolar disorder: A systematic review. Journal of affective disorders,326, 232–242. Advance online publication.
Tyler, E Lobban, F, Sutton, C Hadarag, BH Johnson, S Depp, C Duncan D.,Jones S.H (2022) A pilot randomised controlled trial to assess the feasibility and acceptability of recovery focused therapy for older adults with bipolar disorder. BJPsych Open, Volume 8 , Issue 6.
Tyler E, Lobban F, Hadarag MB, Jones SH. A systematic review of psychosocial functioning and quality of life in older people with bipolar disorder. Journal of Affective Disorders Reports. 2022 May 21:100371.
Tyler E, Lobban F, Long R, Jones SH. Developing a recovery-focused therapy for older people with bipolar disorder: a qualitative focus group study. BMJ Open. 2021 Aug 4;11(8):e049829.
Smart, E., Berry, K., Palmier-Claus, J. & Brown, L. (2021). Aging well with psychosis. Journal of Aging Studies, 57, 100925

Open days



Register your interest for this project



Where will I study?

Faculty of Biology, Medicine and Health

Tackle real world challenges, make a difference, and elevate your career with postgraduate research in the Faculty of Biology, Medicine and Health at Manchester. From biochemistry to neuroscience, cancer sciences to medicine, audiology to mental health and everything in between, we offer a wide range of postgraduate research projects, programmes and funding which will allow you to immerse yourself in an area of research you’re passionate about.

Why study at Faculty of Biology, Medicine and Health?

Ranked the best place to live in the UK (The Economist Global Liveability Index, 2022), Manchester boasts world-class culture, iconic sports, a thriving music and food scene, and much more. It’s not just a place to research, it’s a place to call home.

Experience PhD life as part of a diverse postgraduate research community of more than 1,000 postgraduate researchers at the 29th most international university in the world (Times Higher Education, 2023).

With 93% of research activity at the University rated as ‘world-leading’ or ‘internationally excellent’ (Research Impact Framework, 2021), you’ll get the chance to have an impact on global health and science challenges.

1000+

postgraduate students

94

PhDs

6

ranked in UK - QS (2025)

Manchester  United Kingdom

main campus

Upcoming Open Days & Webinars

16

Sep 2024

The University of Manchester

Webinars and Open Days at the Faculty of Biology, Medicine and Health

 Manchester


About Faculty of Biology, Medicine and Health

At Manchester, postgraduate researchers are at the heart of our mission to tackle pressing global challenges in biological, medical and healthcare sciences - and you could be too.

By choosing Manchester for your postgraduate research, you’ll be joining a university with an exceptional research reputation, where 93% of research is world-leading or internationally excellent (REF, 2021) and where your work will have real-world impact.

You’ll research in world-class facilities alongside leading experts at the forefront of innovation, collaborating across disciplines to pioneer new treatments, advance scientific knowledge, and improve healthcare globally.

Supported by our dedicated Doctoral Academy and strong industry links, you'll experience PhD life in a vibrant, welcoming and diverse postgraduate research community.

And you’ll leave with the specialist knowledge, research experience and transferable skills that will shape your future in academia, research or industry.





Main campus

The University of Manchester

Manchester

North West

United Kingdom

PhD saved sucessfully

A novel role in mitochondrial homeostasis for the anti-ageing factor RBBP5

The mitochondrion has evolved from the endosymbiotic interaction of an alpha-proteobacterium and an archaeon. One major event during this evolution was the transferring of genes from the symbiont to the host. Read more
More details

Bioinspired Nanomaterials Based Miniaturised Soft Robots for High Precision Regiospecific Drug Delivery to Malignant Tumours

Cancer is one of the top global public health challenges, estimated to have caused 10M deaths (2020) according to WHO. Throughout the years, standardised therapeutic protocols have been developed and evolved for the treatment of various types of cancers. Read more
More details

Can the Reboot coaching programme support general practitioners in coping with adverse events? Adaptation and evaluation of a novel intervention

Are you interested in mental health research? Would you like to support healthcare professionals to deliver safer patient care? Please see below for an exciting PhD research project which offers the opportunity to develop a range of research skills. Read more
More details

Cell-matrix interface engineering for regenerative medicine applications and disease modelling

Dr. Mahetab Amer is seeking motivated students with backgrounds in tissue engineering, cell biology, materials science, or related fields to join her dynamic, multidisciplinary research group at the Division of Cell Matrix Biology and Regenerative Medicine, University of Manchester. Read more
More details

Chaperones and the response to protein misfolding stress

Misfolded proteins are usually refolded to their functional conformations or degraded by quality control mechanisms. When misfolded proteins evade quality control, they form aggregates that are sequestered to specific sites within cells. Read more
More details

Clinical Prediction Modelling under Federated Learning

Clinical prediction models (CPMs) take a set of characteristics about a patient to estimate their risk of an event of interest. Developing CPMs using data that captures observations across multiple clusters (e.g., countries) can increase the robustness and generalisability of CPMs. Read more
More details

Decoding the epigenetic mechanisms of drug resistance in aggressive breast cancers

Breast cancers pose a major health burden to modern world as being the most common cancer in women. Estrogen receptor (ER), the classical marker of 70% these cancers, is the nuclear receptor important for cancer progression. Read more
More details

Defining the molecular mechanisms of leukaemia chemotherapies

Chemotherapies are usually the backbone of cancer treatment for either curative or palliative patient care. Multiple therapies can be used for the same disease, with the choice of drug dependent on parameters such as the patient’s age and fitness. Read more
More details

Delineating the IRF6 regulatory network driving periderm formation and function

During development, the ectoderm passes through a series of cell states to produce a self-replenishing, multi-layered epidermis. Initial stratification forms a single-cell layer of flattened periderm cells which act as a barrier to prevent pathological adhesions during embryogenesis. Read more
More details

Diagnostics for FMF patients and carrier survival in pandemics

Background. Familial Mediterranean Fever (FMF) is a rare inherited genetic disease where patients acquire a mutation on the pyrin gene leading to excessive inflammasome activation and excessive inflammation. Read more
More details

Driving phenotypic plasticity and metastasis in small cell lung cancer

Small cell lung cancer (SCLC) is an aggressive malignancy with poor prognosis. Underlying this aggressiveness is intra-tumoural heterogeneity driven by phenotypic plasticity wherein tumour cells transition from a neuroendocrine (NE) to a non-neuroendocrine (non-NE) phenotype. Read more
More details

Dysfunctional antifungal potency of the respiratory mucosa in COPD

Inhalation of Aspergillus fumigatus spores cause >3,000,000 chronic and >200,000 invasive diseases annually worldwide. Invasive aspergillosis carries a 50% mortality rate overall, but mortality rate approaches 100% if diagnosis is delayed or missed and it is >75% in certain cohorts of patients, such as COPD sufferers. Read more
More details

Early life factors in the development of Juvenile idiopathic arthritis

Juvenile idiopathic arthritis (JIA) is an autoimmune inflammatory arthritis with disease onset before the age of 16. Children and young people with this condition develop painful swollen joints and untreated it can lead to long term disability. It may also be associated with comorbid conditions such as uveitis. Read more
More details

Identifying and minimising problematic polypharmacy in older patients admitted to critical care

This PhD will identify the effects of admission to critical care on medication-related risks in older patients (≥65 years of age), leading to the development of an in-hospital intervention suitable for routine implementation in clinical practice and future evaluation. Read more
More details

Inducing ferroptotic death to kill cancer cells

Ferroptosis is an iron-dependent form of regulated necrotic cell death triggered by oxidative degradation of lipids in membrane bilayers and subsequent irreparable damages to the plasma membrane (1). Read more
More details

Intrinsic mechanisms of axonal regeneration following peripheral nerve injury

Peripheral nerve injury (PNI) is a common consequence of trauma with life-changing implications both physically (loss of limb function) and psychologically (impact on employment, personal relationships and wider wellbeing). Read more
More details

Investigating monogenic disorders of the protein synthesis machinery

Translation of mRNA into proteins is a critical cellular biological process. We recently described a novel human disorder, now called Faundes-Banka Syndrome (FABAS), caused by heterozygous variants in EIF5A1 that encodes a translation factor. Read more
More details

Investigating the cardio-pulmonary impact of airborne nanoplastics

There is growing evidence that humans are exposed to incidental microplastics and nanoplastics (MNPL) particles through inhalation and that the small size of these particles may allow for bioaccumulation and retention in the body. Read more
More details

Mechanistic analysis of neurodevelopmental disorders caused by mutations in the gene RAC1

RAC1 is a signalling protein that regulates many cellular processes and is essential during embryonic development. We recently discovered a novel genetic disease called RAC1-related neurodevelopmental disorder (RAC1-NDD) that results from mutations in the RAC1 gene. Read more
More details

Modelling the ecology and evolution of microbial communities

From the human gut to deep-sea sediments, microbial communities – or microbiomes – colonize virtually every habitat on earth. These microbiomes are central to ecosystem functioning and to host health, and therefore it is essential that we understand how and why they change over time. Read more
More details